Athens Research/Cambio - Excellence in Molecular Biology/0.25g/10-1028-02

价格
面议
货号:10-1028-02
浏览量:127
品牌:Athens Research
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Oligo Synthesis

Oligo Synthesis : CEPs

Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen"sproductsarehazardousandmay be subject to additional shipping charges. Full product information is available onGlen Research"s website.

  • Catalogue
  • Description
  • Protocols
  • Notes
  • Applications & Benefits

8-oxo-dG-CE Phosphoramidite

8-oxo-dG-CE Phosphoramidite

Glen Research

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
  • €
10-1028-028-oxo-dG-CE Phosphoramidite0.25g£780.00£741.00Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order
10-1028-908-oxo-dG-CE Phosphoramidite100µmoles£284.00£269.80Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order
10-1028-958-oxo-dG-CE Phosphoramidite50µmoles£142.00£134.90Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order

8-oxo-dG-CE Phosphoramidite

8-oxo-dG-CE Phosphoramidite

Glen Research

8-oxo-dG-CE Phosphoramidite

Structure

Catalog Number: 10-1028-xx

Description: 8-oxo-dG-CE Phosphoramidite

5"-Dimethoxytrityl-N2-isobutyryl-8-oxo-deoxyGuanosine-3"-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite
Formula: C44H54N7O9PM.W.: 855.93F.W.: 345.21

Diluent: Anhydrous Acetonitrile
Coupling: No changes needed from standard method recommended by synthesizer manufacturer.
Deprotection: Cleave and deprotect with ammonium hydroxide containing 0.25M 2-mercaptoethanol 17 hours at 55°C to avoid oxidative degradation of the 8-oxo-dG site.
Storage: Refrigerated storage, maximum of 2-8°C, dry

Stability in Solution: 24 hours

DNA Damage/Repair

Cellular DNA is constantly being damaged by oxidation andalkylation, by free radicals, and by ultraviolet and ionizing radiation. Thebody has therefore evolved a number of repair enzyme systems to excise andrepair these lesions. The 8-oxo purine monomers allow investigation of thestructure and activity of oligonucleotides containing an 8-oxo mutation which isformed naturally when DNA is subjected to oxidative conditions or ionizingradiation. 5,6-Dihydro pyrimidines are naturally occurring compounds that arestructural components of alanine transfer RNA. Dihydrouracil and the hydroxypyrimidines are major base damage products formed by exposure of DNA to ionizingradiation.

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

8-oxo-dG-CE Phosphoramidite

8-oxo-dG-CE Phosphoramidite

Glen Research

MSDS

Glen Report 7.1: NEW MINOR BASES

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

8-oxo-dG-CE Phosphoramidite

8-oxo-dG-CE Phosphoramidite

Glen Research

Synthetic oligonucleotides containing 8-oxo-dG must be cleaved and deprotected with ammonium hydroxide containing 0.25M 2-mercaptoethanol to avoid oxidative degradation of 8-oxo-dG sites.

Frequently Asked Technical Question

QUESTION: How do you deprotect 8-oxo-dG?

RESPONSE:Cleave and deprotect with ammonium hydroxide containing 0.25M 2-mercaptoethanol 17 hours at 55°C to avoid oxidative degradation of the 8-oxo-dG site

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

8-oxo-dG-CE Phosphoramidite

8-oxo-dG-CE Phosphoramidite

Glen Research

EXTINCTION DATA

ItemNucleosideλMax-1Emax-1λMax-2Emax-2E260
(nm)(ml/µmole)nm(ml/µmole)(ml/µmole)
10-10288-oxo-dG2945.22506.75.9

DILUTION/COUPLING DATA

The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures. Please link for more detailed usage information with the various synthesizers.

ABI 392/394
Cat.No.PackSizeGrams/Pack0.1M Dil.(mL)LV40LV20040nm0.2µm1µm10µm
Approximate Number of Additions
10-1028-020.25grams.25grams2.928450.431.522.9116.84.2
10-1028-90100µmoles.086grams120127.55.4541
10-1028-9550µmoles.043grams.53.3321.25.91.67.17
Expedite
Cat.No.PackSizeGrams/PackDilution(mL)Molarity50nm0.2µm1µm15µm
Approximate Number of Additions
10-1028-020.25grams.25grams4.36.0780.850.536.735.05
10-1028-90100µmoles.086grams1.5.0723.614.7510.731.48
10-1028-9550µmoles.043grams.75.078.65.383.91.54
Beckman
Cat.No.PackSizeGrams/PackDilution(mL)Molarity30nm200nm1000nm
Approximate Number of Additions
10-1028-020.25grams.25grams4.36.0782.451.537.45
10-1028-90100µmoles.086grams1.5.0725.215.7511.45
10-1028-9550µmoles.043grams.75.0710.26.384.64

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Myeloperoxidase Enzyme Immunoassay Kit 髓过氧化物酶 免疫分析试剂盒 Human MPO EIA KIT FEATURES: USE - Measure human MPO in a variety of matrices SAMPLE -Serum, Platelet-Poor Heparin Plasma, Saliva, Urine or Tissue Culture Media SAMPLES / KIT - 40 in duplicate SENSITIVITY - 0.068 ng/mL STABILITY - liquid reagents stable at 4°C QUICK RESULTS - 2.5 HOURS Myeloperoxidase (MPO) is a tetrameric heme-containing protein abundantly produced in neutrophil granulocytes where it plays an important anti-microbial role. During degranulation MPO is released into the extracellular space. There, as part of the neutrophils “respiratory burst”, it produces hypochlorous acid from hydrogen peroxide and Cl–. MPO also uses hydrogen peroxide to oxidize tyrosine to the tyrosyl radical. Both hypochlorous acid and tyrosyl are cytotoxic and when present can kill bacteria and other pathogens. Hereditary deficiency of myeloperoxidase predisposes individuals to immune deficiency. Studies have shown an association between elevated MPO levels and coronary artery disease, and in 2003 it was suggested that MPO may serve as a sensitive predictor of myocardial infarction in patients complaining of chest pain. Since that time the clinical utility of MPO testing in cardiac patients has been solidly established in the literature with well over 100 papers published. In 2010 this clinical application was further refined by additional studies which determined that measuring both MPO and C-reactive protein (CRP) provided more accurate prediction of mortality risk than measuring just CRP alone.